Found: 14
Select item for more details and to access through your institution.
Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 9, p. 1412, doi. 10.3390/life12091412
- By:
- Publication type:
- Article
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 191, doi. 10.1002/jvc2.275
- By:
- Publication type:
- Article
Brodalumab: Efficacy, safety, and survival in mid‐term (52 weeks) on real clinical practice in Andalucia, Spain.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 5, p. 700, doi. 10.1111/ijd.16527
- By:
- Publication type:
- Article
Super responders to guselkumab treatment in moderate‐to‐severe psoriasis: a real clinical practice pilot series.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 8, p. 1029, doi. 10.1111/ijd.15784
- By:
- Publication type:
- Article
Drug survival, discontinuation rates, and safety profile of secukinumab in real‐world patients: a 152‐week, multicenter, retrospective study.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 5, p. 633, doi. 10.1111/ijd.14819
- By:
- Publication type:
- Article
Frontal Congenital Lipoma.
- Published in:
- Pediatric Dermatology, 2012, v. 29, n. 4, p. 490, doi. 10.1111/j.1525-1470.2011.01526.x
- By:
- Publication type:
- Article
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.12314
- By:
- Publication type:
- Article
Guselkumab dosing interval optimization in adult patients with moderate‐to‐severe psoriasis switching from ustekinumab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15835
- By:
- Publication type:
- Article
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 85, n. 2, p. 186, doi. 10.1111/cod.13833
- By:
- Publication type:
- Article
Frequency of sensitization to the individual fragrances of fragrance mix I and II according to the factors included in the MOAHLFA index.
- Published in:
- Contact Dermatitis (01051873), 2021, v. 84, n. 6, p. 395, doi. 10.1111/cod.13801
- By:
- Publication type:
- Article
Trend of relevant contact allergens of the feet in Spain over a period of 10 years.
- Published in:
- Contact Dermatitis (01051873), 2020, v. 82, n. 4, p. 211, doi. 10.1111/cod.13419
- By:
- Publication type:
- Article
Sensitization to fragrances in Spain: A 5‐year multicentre study (2011‐2015).
- Published in:
- Contact Dermatitis (01051873), 2019, v. 80, n. 2, p. 94, doi. 10.1111/cod.13152
- By:
- Publication type:
- Article
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 9, p. 991, doi. 10.1093/ced/llad153
- By:
- Publication type:
- Article
Severe Atopic Dermatitis In Spain: A Real-Life Observational Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article